• KOLs Community
    • Racemic
    • Racemic Albuterol
    • Kenneth Tripp
    • Kenneth Tripp

      Kenneth Tripp

      Sepracor, Inc, Marlborough, Mass | Sepracor Inc, Marlborough, Massachusetts | Sepracor Inc., Marlborough, MA, USA



      KOL Resume for Kenneth Tripp


      Sepracor, Inc, Marlborough, Mass


      Sepracor Inc, Marlborough, Massachusetts


      Sepracor Inc., Marlborough, MA, USA



      Kenneth Tripp: Influence Statistics

      Sample of concepts for which Kenneth Tripp is among the top experts in the world.
      Concept World rank
      hfa mdi improvements #5
      events levalbuterol #5
      mdi racemic #5
      ralbuterol levels #5
      adverse events levalbuterol #5
      heart rate levalbuterol #5
      16 cumulative doses #5
      rate ralbuterol #5
      levalbuterol metereddose inhaler #5
      hydrofluoroalkane134a metered #5
      doses 8x #5
      hfa cumulative doses #5
      dosing asthmatic #5
      52 weeks regular #5
      95 16x dose #5
      rate levalbuterol #5
      dose racemic albuterol #5
      regular levalbuterol #5
      hfa cumulative #5
      16x dose #5
      16x levalbuterol #5
      plasma ralbuterol #5
      hfa administered #5
      hfa levalbuterol #6
      metereddose inhaler patients #6
      hfa racemic #6
      hfa mdi hfa #6
      subjects levalbuterol #6
      racemic albuterol hfa #6
      levalbuterol hfa #6
      levalbuterol hfa mdi #6
      mdi asthmatic #6
      dosing levalbuterol #6
      8x greater #7
      cumulative dose study #8
      hfa hfa mdi #8
      ralbuterol plasma #9
      mdi dosing #9
      levalbuterol administered #9
      safety levalbuterol #10
      actuations 90 #12
      greater racemic #12
      hfa metered #13
      8x dose #13
      mdi 90 #13
      doses levalbuterol #14
      inhalers spirometry #14
      study levalbuterol #16
      asthma adverse events #16
      90 microg dose #17


      Prominent publications by Kenneth Tripp

      KOL-Index: 6645

      OBJECTIVE: To evaluate the efficacy and safety of levalbuterol metered dose inhaler (MDI) in children aged 4-11 years (n = 173).

      RESEARCH DESIGN AND METHODS: Multicenter, randomized, double-blind 28-day study of QID levalbuterol 90 microg, racemic albuterol 180 mug, and placebo (2:1:1 ratio). Serial spirometry was performed on Days 0, 14, and 28. The primary endpoint was the double-blind average peak percent (%) change in FEV(1) from visit pre-dose; the primary comparison was with ...

      Known for Racemic Albuterol | Metered Dose | Patients Asthma | 90 Microg | Administration Inhalation
      KOL-Index: 5705

      BACKGROUND: Previous studies have raised concerns regarding the safety of regular use of beta2-agonists for treating asthma. Few studies have explored the safety of at least 1 year of use of racemic albuterol, and none have examined long-term dosing of levalbuterol.

      OBJECTIVE: To examine the long-term safety of levalbuterol hydrofluoroalkane (HFA) vs racemic albuterol HFA administered via metered-dose inhaler (MDI) in patients with stable asthma.

      METHODS: Patients with mild to moderate ...

      Known for Racemic Albuterol | Patients Asthma | Term Safety | Beta Agonists | Administration Inhalation
      KOL-Index: 2230

      BACKGROUND: The short-acting beta(2)-agonists levalbuterol and racemic albuterol are available for administration through a hydrofluoroalkane-134a (HFA) metered-dose inhaler (MDI).

      OBJECTIVE: This study compared the short-term safety and efficacy of cumulative doses of levalbuterol HFA MDI and racemic albuterol HFA MDI in asthmatic subjects.

      METHODS: This was a randomized, modified-blind, active-controlled, multicenter, 2-way crossover study. Subjects (n = 49) were randomized to 16 ...

      Known for Racemic Albuterol | Beta Agonists | Bronchodilator Agents | Short Acting

      Key People For Racemic Albuterol

      Top KOLs in the world
      Sidney S DeGraw
      racemic albuterol pediatric patients placebo treatment
      George W Bensch
      pulmicort turbuhaler mometasone furoate racemic albuterol
      David S Reasner
      racemic albuterol pediatric patients placebo treatment
      Harold S Nelson
      allergic rhinitis sublingual immunotherapy inhaled corticosteroids
      Warren W Pleskow
      racemic albuterol fluticasone propionate seasonal allergic rhinitis
      Thomas E Rollins
      racemic albuterol improved bronchodilation patients asthma

      Kenneth Tripp:Expert Impact

      Concepts for whichKenneth Tripphas direct influence:Racemic albuterol,  Asthmatic subjects,  Levalbuterol hfa mdi,  Levalbuterol racemic albuterol,  Adverse events levalbuterol,  Hfa mdi,  90 microg,  Levalbuterol hfa.

      Kenneth Tripp:KOL impact

      Concepts related to the work of other authors for whichfor which Kenneth Tripp has influence:Racemic albuterol,  Inhaled corticosteroids,  Acute asthma,  Lev rac,  Anticholinergics children,  Week safety.



      Is this your profile? manage_accounts Claim your profile content_copy Copy URL code Embed Link to your profile

      Sepracor, Inc, Marlborough, Mass | Sepracor Inc, Marlborough, Massachusetts | Sepracor Inc., Marlborough, MA, USA

    Download on the App StoreGet it on Google Play

    Copyright © 2023 - KOL means Key Opinion Leaders .

    KOL does not provide medical advice, diagnosis or treatment.